Meloxicam: profile and news

Vulture decline: Pressure builds to ban Diclofenac Feb 8, 2006
Meanwhile, scientists with the Indian Veterinary Research Institute have conducted a study on Meloxicam, as a replacement to Dicofenac. ... - Hindu Business Line,

Rarest vultures join breeding programme Feb 28, 2006
Although a new alternative, meloxicam, that is not harmful to vultures has been identified, two captive breeding centres have been set up in the meantime. ... - BirdLife International,

BirdLife hopeful of diclofenac ban Feb 1, 2006
At a two-day meeting finishing today, the Indian government opted to await the results of final tests on the proposed replacement, meloxicam, which are due ... - BirdLife International,

Forest dept to support drug ban to save vultures Feb 5, 2006
...that the Asian vultures can be saved if the inflammatory drug — diclofenac — mainly found in dead cattle, is replaced by a new drug meloxicam, the Nadia ... - The Statesman,

UK: GOVERNMENTS, NGOS AND SCIENTISTS UNITE TO SAVE VULTURES FROM ... Feb 5, 2006
A team of scientists from South Africa, Namibia, India and the UK has now found an equally effective but non toxic drug - Meloxicam. ... - noticias.info,

Medication for endangered vultures offers hope Feb 1, 2006
...the scientists from Britain, India, South Africa and Namibia said diclofenac -- which is fatal to the birds -- could readily be replaced by meloxicam which is ... - Zee News,

Bird groups hopeful on vultures Feb 1, 2006
...drug before taking a decision. A study reported this week showed meloxicam to be a safe alternative. The three species most seriously ... - BBC News,

Ray of hope for vultures facing extinction Feb 1, 2006
The team, led by Gerry Swan of the University of Pretoria, found that the drug meloxicam was safe to vultures at the likely range of levels they would be ... - 999 Today,

Switching Drug For Livestock May Save Endangered Vultures Feb 2, 2006
Meloxicam, a nonsteroidal anti-inflammatory drug, has been shown to be a safe and effective replacement for diclofenac, a widely used veterinary NSAID that has ... - Chemical & Engineering News

Drug India Uses in Cattle Is Killing Off Vultures Feb 4, 2006
But an international team reported in the current issue of the journal Public Library of Science Biology that the drug meloxicam is as effective as diclofenac ... - Los Angeles Times,

Alternative Drug Could Save Asian Vultures Jan 31, 2006
The study by scientists from South Africa, Namibia, India and Britain concluded that another drug, meloxicam, was just as effective in livestock and was safe ... - Bernama,

Vets Issue Vulture Death Warning Feb 6, 2006
A group of scientists, which include those of Namibia, South Africa, Britain and India, found that meloxicam, a drug that is similar to dicoflacen, was just in ... - AllAfrica.com,

- By Our Correspondent Feb 3, 2006
...population in the country caused by diclofenac, a joint team of scientists from India, South Africa and UK has claimed that another drug, meloxicam is an ... - The Asian Age,

Safe pickings needed for India's vultures Feb 2, 2006
...asking zoo vets around the world for their experience, Rhys Green of the University of Cambridge and colleagues have shown that the painkiller meloxicam can be ... - New Scientist (subscription),

REGIONAL COOPERATION AMONG VULTURE RANGE COUNTRIES RECOMMENDED ... Feb 1, 2006
The drug meloxicam has been thoroughly tested by Indian and foreign scientists and has been conclusively proved to be a safe and viable substitute for ... - Press Information Bureau (press release),

Earthweek: A Diary of a Planet Feb 7, 2006
...produce it. Scientists say a switch to the use of meloxicam, which does not harm the birds, could resolve the crisis. They also ... - Gilroy Dispatch (subscription),

India to ban drug blamed in vulture deaths Jan 31, 2006
...published in the British journal PLoS Biology, a team of scientists from South Africa, Namibia, Britain and India said they had found that meloxicam, a drug ... - San Jose Mercury News,

Cooperation among countries suggested for saving vultures Feb 1, 2006
...effects of Diclofenac. The drug Meloxicam has been proved to be a safe and viable substitute for Diclofenac. "Hence department of ... - Zee News,

Phase out diclofenac to save vultures: experts Feb 1, 2006
In place of diclofenac, the experts attending the conference recommended using meloxicam, which has been thoroughly tested by scientists and "has been ... - Webindia123,

Experts for banning use of diclofenac on vultures Feb 1, 2006
They recommended the use of drug meloxicam which they said had been thoroughly tested by Indian and foreign scientists and had been conclusively proved to be a ... - Webindia123,

Namibian in bid by scientists to save vultures in Asia Feb 2, 2006
...the scientists from Britain, India, South Africa and Namibia said diclofenac - which is fatal to the birds - could readily be replaced by meloxicam which is not ... - African News Dimension,

Drug swap urged to save vultures Jan 30, 2006
...carcasses. A study published by the Public Library of Science says an alternative drug, meloxicam, is harmless to vultures. Protecting ... - BBC News,

Scientists Discover Remedy To Save Vultures Jan 31, 2006
...inflammatory drug, diclofenac. The research team suggests replacing diclofenac with the non-threatening drug meloxicam. The scientists ... - All Headline News

Scientists formulate Indian vulture rescue plan Jan 31, 2006
...toxic carrion. However, there is a simple soultion - replace diclofenac with meloxicam which is not poisonous to vultures. That, says ... - Register,

Cattle drug blamed as India's vultures near extinction Jan 31, 2006
Conservationists pushing for a ban say their case is bolstered by the discovery of a vulture-friendly alternative cattle drug, called meloxicam. ... - Guardian Unlimited,

Ray of Hope for Vultures Facing Extinction Jan 31, 2006
The team, led by Gerry Swan of the University of Pretoria, found that the drug meloxicam was safe to vultures at the likely range of levels they would be ... - innovations report,

New drug offers vulture lifeline Jan 31, 2006
In a new report published in PLoS Biology, a team of scientists led by Gerry Swan of the University of Pretoria, found that the drug meloxicam was safe to ... - BirdLife International,

Vultures driven towards extinction by painkiller Jan 30, 2006
A study published today in the online journal Public Library of Science, has shown that a painkiller called meloxicam is safe to vultures in the concentrations ... - Independent,

Alternative drug could save vultures Jan 30, 2006
A study by scientists from South Africa, Namibia, India and Britain concluded that another drug, meloxicam, was just as effective in livestock and was safe to ... - Telegraph.co.uk,

Scientists reportedly find new cattle drug Jan 30, 2006
Tuesday in the British journal PLoS Biology, a team of scientists from South Africa, Namibia, Britain and India said they had found that meloxicam, a drug ... - San Jose Mercury News,

Block That Chirp: Volume Control in Crickets Jan 30, 2006
...international team of researchers led by Gerry Swan of the University of Pretoria in South Africa discovered that another cattle painkiller, meloxicam, is not ... - New York Times,

Abbott shares rise on Q4 and Guidant win Jan 26, 2006
...fenofibrate), up 37.5% to $312 million; the antibiotic Omnicef (cefdinir), rising 27.5% to $189 million; and the osteoarthritis drug Mobic (meloxicam), sold by ... - Pharma Times (subscription),

Drug swap urged to save vultures Jan 31, 2006
...animal carcasses. A study published by the Public Library of Science says an alternative drug, meloxicam, is harmless to vultures. - addict3d.org

Visiting Veterinarian: Arthritis pain relief for Rover Dec 7, 2005
COX-2 and spare COX-1. Prescription NSAIDs for dogs include carprofen (Rimadyl), deracoxib (Deramaxx), etodolac (Etogesic), meloxicam (Metacam), tepoxalin ... - Martha's Vineyard Times,

Boehringer Ingelheim/Biolipox: a pain-free partnership Nov 16, 2005
...concerns. Meanwhile, Boehringer has seen sales of its Abbott Laboratories co-marketed NSAID Mobic (meloxicam), increase dramatically. ... - Pharmaceutical Business Review

NSAIDs too? Oct 1, 2005
These patients started taking drugs like naproxen, ibuprofen, diclofenac and meloxicam again, in the hopes that these would be safer in terms of cardiovascular ... - Malaysia Star,

What next? Oct 1, 2005
These are the studies we need: celecoxib versus meloxicam, celecoxib versus diclofenac and celecoxib versus naproxen,�? stresses Dr Ruschitzka. ... - Malaysia Star,

CHMP review of safety of non-selective NSAIDs, EMEA 06 Aug 2005
...this review? Diclofenac, Etodolac, Ibuprofen, Indomethacin, Ketoprofen, Meloxicam, Nabumetone, Naproxen and Nimesulide. As part ... - I-Newswire.com (press release)

EMEA on the Cardiovascular Safety of Non-Selective NSAIDs Aug 2, 2005
...this review (whether prescription or non-prescription products) are: Diclofenac, Etodolac, Ibuprofen, Indomethacin, Ketoprofen, Meloxicam, Nabumetone, Naproxen ... - PharmaLive.com (press release)

Neuropathic Pain Market to Reach $3.5 Billion by 2014, Despite ... Jul 11, 2005
Neurobiological Technologies / Merz) and lamotrigine (GlaxoSmithKline / Bristol-Myers Squibb); cyclo-oxygenase inhibitors meloxicam (Boehringer Ingelheim ... - Yahoo News (press release)

Abbott Laboratories: arthritis drugs lift profits Jul 19, 2005
Strong sales from Humira (adalimumab) and Mobic (meloxicam, co-marketed with Boehringer Ingelheim) helped Abbott's [ABT] second quarter 2005 earnings jump by 38 ... - Pharmaceutical Business Review <**results**>

Neuropathic Pain Market to Reach $3.5 Billion by 2014, Despite ... 11 Jul 2005
Neurobiological Technologies / Merz) and lamotrigine (GlaxoSmithKline / Bristol-Myers Squibb); cyclo-oxygenase inhibitors meloxicam (Boehringer Ingelheim ... - Yahoo News (press release)

The Arthritis Pills With a Bigger Heart Risk Than Ibuprofen Jun 12, 2005
...those taking indomethacin, which goes under the brand name Indomod or Indocid, 41 per cent for those on sulindac (Clinoril) and 37 per cent for meloxicam (Mobic ... - RedNova.com,

Other information

Indication
For the treatment of arthritis and osteoarthritis

Pharmacology
Meloxicam is an nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Prostaglandins are substances that contribute to inflammation of joints. Meloxicam inhibits prostaglandin synthetase (cylooxygenase 1 and 2) and leads to a decrease of the synthesis of prostaglandins, therefore, inflammation is reduced.

Mechanism Of Action
Anti-inflammatory effects of Meloxicam are believed to be due to inhibition of prostaglandin synthetase (cylooxygenase), leading to the inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis may be associated with the analgesic and antipyretic effects of Meloxicam.

Drug Category
Analgesics; Antineoplastic Agents; Antiemetics; Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); Cyclooxygenase Inhibitors; Growth Inhibitors; ATC:M01AC06

Brand Names/Synonyms
Meloxicam; Mobic

Dosage Forms
TABLET

Absorption
89%

Interactions
-->Interactions for Meloxicam:

ACE inhibitors

Reports suggest that NSAIDs may diminish the antihypertensive effect of angiotensin-converting enzyme (ACE) inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors.

Aspirin

Concomitant administration of aspirin (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and C_max (24%) of meloxicam. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of meloxicam and aspirin is not generally recommended because of the potential for increased adverse effects. Concomitant administration of low-dose aspirin with MOBIC may result in an increased rate of GI ulceration or other complications, compared to use of MOBIC alone. MOBIC is not a substitute for aspirin for cardiovascular prophylaxis.

Cholestyramine

Pretreatment for four days with cholestyramine significantly increased the clearance of meloxicam by 50%. This resulted in a decrease in t_1/2, from 19.2 hours to 12.5 hours, and a 35% reduction in AUC. This suggests the existence of a recirculation pathway for meloxicam in the gastrointestinal tract. The clinical relevance of this interaction has not been established.

Cimetidine

Concomitant administration of 200 mg cimetidine QID did not alter the single-dose pharmacokinetics of 30 mg meloxicam.

Digoxin

Meloxicam 15 mg once daily for 7 days did not alter the plasma concentration profile of digoxin after b-acetyldigoxin administration for 7 days at clinical doses. In vitro testing found no protein binding drug interaction between digoxin and meloxicam.

Furosemide

Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients. This effect has been attributed to inhibition of renal prostaglandin synthesis. Studies with furosemide agents and meloxicam have not demonstrated a reduction in natriuretic effect. Furosemide single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of meloxicam. Nevertheless, during concomitant therapy with furosemide and MOBIC, patients should be observed closely for signs of declining renal function, as well as to assure diuretic efficacy.

Lithium

In clinical trials, NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving lithium alone. These effects have been attributed to inhibition of renal prostaglandin synthesis by MOBIC. Patients on lithium treatment should be closely monitored when MOBIC is introduced or withdrawn.

Methotrexate

A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of meloxicam on the pharmacokinetics of methotrexate taken once weekly. Meloxicam did not have a significant effect on the pharmacokinetics of single doses of methotrexate. In vitro, methotrexate did not displace meloxicam from its human serum binding sites.

Warfarin

Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing MOBIC therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding. The effect of meloxicam on the anticoagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of warfarin that produced an INR (International Normalized Ratio) between 1.2 and 1.8. In these subjects, meloxicam did not alter warfarin pharmacokinetics and the average anticoagulant effect of warfarin as determined by prothrombin time. However, one subject showed an increase in INR from 1.5 to 2.1. Caution should be used when administering MOBIC with warfarin since patients on warfarin may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.

Chemical IUPAC Name
9-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-8-methyl-7,7-dioxo-7$l^{6}-thia-8-azabicyclo[4.4.0]deca-1,3,5-trien-10-one

Chemical Formula
C14H13N3O4S2

Half Life
15 hours-20 hours

Drug Type
Approved Drug

# Accession No
APRD00529

CAS Registry Number
71125-38-7